Anorexia Nervosa: Neurobehavioral Mechanisms, DSM-5 Criteria, Medical Complications, and Evidence-Based Treatment

Anorexia nervosa (AN) is a severe, potentially life-threatening eating disorder characterized by restricted energy intake, intense fear of gaining weight, and disturbance in the way one’s body weight or shape is experienced. Although popular discussion often frames AN as a lifestyle choice, clinically it is a neurobehavioral syndrome with biopsychosocial drivers. The condition typically begins in adolescence or early adulthood, but it can occur across the lifespan.

Core psychopathology centers on restrictive eating behaviors, cognitive distortions regarding body image, and anxiety/avoidance related to weight gain. A defining feature is that the individual’s self-evaluation is unduly influenced by perceived weight and shape. Physiologically, chronic undernutrition triggers adaptive responses—such as reduced metabolic rate, neuroendocrine changes, and alterations in gastrointestinal function—that can perpetuate the disorder by reinforcing energy conservation and blunting appetite signals. Malnutrition also affects neural circuits involved in reward processing, stress regulation, and executive control, contributing to rigid dietary rules and impaired flexibility in eating behavior.

Diagnostic frameworks rely on DSM-5 criteria: (1) restriction leading to significantly low body weight for age, sex, developmental trajectory, and physical health; (2) intense fear of gaining weight or persistent behavior that interferes with weight gain; and (3) disturbance in the way one’s body weight or shape is experienced, including overvaluation of weight/shape or denial of severity. AN is further specified by subtype: restricting type versus binge-eating/purging type. Clinicians must also assess comorbidities such as major depressive disorder, obsessive-compulsive disorder traits, post-traumatic stress symptoms, and substance use, as these influence risk, treatment planning, and relapse probability.

Medical complications are extensive and can be immediate. Cardiovascular effects include bradycardia, hypotension, orthostatic changes, and increased risk of arrhythmias due to electrolyte abnormalities (e.g., hypokalemia) and myocardial changes. Gastrointestinal complications may manifest as constipation, delayed gastric emptying, reflux, and bloating. Endocrine consequences include hypogonadism with amenorrhea, reduced thyroid hormone conversion patterns, altered cortisol rhythms, and impacts on bone mineral density. Skeletal health is a major concern: prolonged undernutrition disrupts bone remodeling, increases fracture risk, and may lead to osteopenia or osteoporosis. Hematologic abnormalities such as anemia or leukopenia can occur, reflecting broad impacts on hematopoiesis.

Refeeding syndrome is a critical complication when nutritional rehabilitation begins after prolonged starvation. As carbohydrate intake increases, insulin secretion drives a shift of phosphate, potassium, and magnesium into cells, leading to potentially fatal hypophosphatemia, arrhythmias, respiratory failure, and neurologic manifestations. Prevention involves careful risk stratification, slow initiation of calories, electrolyte monitoring, and prophylactic supplementation when indicated, along with close vital-sign surveillance.

Psychologically, AN is maintained by a cycle of restriction and short-term relief of distress, followed by reinforcement of fear-related cognitions and heightened preoccupation with body metrics. Cognitive distortions and perfectionistic traits can amplify the disorder’s rigidity. Behavioral factors include avoidance of eating in feared contexts, ritualized food preparation, and excessive exercise. Social determinants—such as cultural pressures around thinness, interpersonal conflict, trauma exposure, and family dynamics—can increase vulnerability and sustain symptoms.

Evidence-based treatment integrates nutritional rehabilitation, psychotherapy, and management of comorbid symptoms. First-line outpatient approaches often include cognitive behavioral therapy tailored for eating disorders (CBT-ED) and family-based treatment (FBT), particularly effective for adolescents because it mobilizes caregivers to support weight restoration while reducing conflict around food. For adults or in more complex cases, specialized CBT-E and dialectical behavior therapy–informed strategies may be used when emotion dysregulation is prominent. Pharmacotherapy does not “cure” core AN behaviors, but it can address comorbid depression, anxiety, or obsessive-compulsive symptoms. Antidepressants may be considered after partial weight restoration or when depressive and anxiety syndromes are clinically significant, though careful monitoring is required.

Hospitalization or higher-acuity care is warranted when there are medical instability signs (e.g., significant bradycardia, syncope, electrolyte derangements, dehydration, dangerously low weight, or rapid weight loss), severe psychiatric risk (e.g., suicidality), or failure of outpatient management. Treatment goals include restoring health parameters, normalizing eating patterns, reducing restrictive and compensatory behaviors, and improving cognitive and emotional flexibility around food and body image. Long-term outcomes vary; early intervention improves prognosis, while relapse risk can remain elevated without ongoing support.

A practical clinical priority is to frame AN as a treatable illness while addressing both medical safety and psychological recovery. Comprehensive care should include dietitian involvement, structured meal planning, monitoring for refeeding risk, and trauma-informed psychotherapy when relevant. Supportive, nonjudgmental communication reduces shame and improves engagement, enabling sustained weight restoration and gradual cognitive restructuring.

Source: https://x.com/lacedangelteeth/status/2067579938384003290